Coldstream Laboratories Names Head of Formulation Development

Article

Coldstream Laboratories names director of formulation development.

Coldstream Laboratories, a provider of sterile drug product development and manufacturing services, has named Adrian Raiche, PhD, as director of formulation development. In this position, Raiche will head the formulation development group at Coldstream and will oversee teams focusing on process and product development, lyophilization, and scale-up activities for manufacturing in the company’s sterile manufacturing facility.

Raiche has experience in several aspects of pharmaceutical development, including lyophilization and potent compound handling.  Most recently, he served as manager of pharmaceutical development at Summit Biosciences contributing to formulation, analytical, and process development of nasal-spray products.  Prior experience includes tenures at SiO2 Medical Products, Brookwood Pharmaceuticals, and Bausch and Lomb. 

Source: Coldstream Laboratories

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content